Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fabrication and Antimycobacterial Evaluation of Molybdenum Disulfide-Coated Titanium Alloy Scaffolds.

ACS omega·2026
Same author

Therapeutic Nanoplatform Integrating Photothermal Effect and Silver Nanoparticles for the Treatment of Intracellular <i>Mycobacterium tuberculosis</i>.

ACS applied materials & interfaces·2026
Same author

Metal-Coordination Spherical Nucleic Acid Combining Antisense Oligonucleotides and Gemcitabine for Chemo-Gene-Chemodynamic Tumor Therapy.

ACS applied materials & interfaces·2026
Same author

Photothermal-Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy.

Advanced healthcare materials·2026
Same author

Correction to "Nano Self-Assembly for Apoptosis Induction and Early Therapeutic Efficacy Monitoring".

Analytical chemistry·2026
Same author

NIR-light triggered photodynamic therapy combined with hypoxia activated chemotherapy for anti-tumor effects.

Nanoscale·2025

Related Experiment Video

Updated: Sep 25, 2025

Synthesis of Core-shell Lanthanide-doped Upconversion Nanocrystals for Cellular Applications
13:51

Synthesis of Core-shell Lanthanide-doped Upconversion Nanocrystals for Cellular Applications

Published on: November 10, 2017

15.5K

Recent advances in functionalized upconversion nanoparticles for light-activated tumor therapy.

Hongqian Chu1,2, Tingming Cao1,2, Guangming Dai1,2

  • 1Translational Medicine Center, Beijing Chest Hospital, Capital Medical University Beijing 101149 PR China sunzhaogang@bjxkyy.cn.

RSC Advances
|May 2, 2022
PubMed
Summary

Upconversion nanoparticles (UCNPs) offer a promising approach for light-activated tumor therapy by converting near-infrared light into UV/visible radiation. These functionalized UCNPs advance cancer treatment options, though clinical application requires further research.

More Related Videos

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.6K
An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.5K

Related Experiment Videos

Last Updated: Sep 25, 2025

Synthesis of Core-shell Lanthanide-doped Upconversion Nanocrystals for Cellular Applications
13:51

Synthesis of Core-shell Lanthanide-doped Upconversion Nanocrystals for Cellular Applications

Published on: November 10, 2017

15.5K
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.6K
An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
11:20

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation

Published on: August 30, 2017

7.5K

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Oncology

Background:

  • Upconversion nanoparticles (UCNPs) are lanthanide-doped nanocrystals with unique optical properties.
  • UCNPs convert near-infrared (NIR) radiation to visible/ultraviolet (UV) light, overcoming limitations of conventional UV-based therapies.
  • They show potential for treating cutaneous diseases, including tumors.

Purpose of the Study:

  • To systematically analyze recent advancements in light-activated tumor therapy using functionalized UCNPs.
  • To summarize the mechanisms of UCNP-based photodynamic therapy (PDT), gene therapy, immunotherapy, chemotherapy, and integrated therapies.
  • To highlight the potential of UCNP-based materials for future cancer treatment innovations.

Main Methods:

  • Literature review of studies on functionalized UCNPs in light-activated tumor therapy.
  • Analysis of UCNP mechanisms in various therapeutic modalities (PDT, gene therapy, immunotherapy, chemotherapy, integrated therapy).
  • Systematic evaluation of UCNP performance and application scope.

Main Results:

  • UCNPs enable controllable tumor therapy by utilizing NIR light, which penetrates deeper and is less damaging than UV light.
  • Functionalized UCNPs have been explored for diverse therapeutic strategies, including PDT, gene therapy, and immunotherapy.
  • Current research is promising but requires further development for clinical translation.

Conclusions:

  • Functionalized UCNPs represent a significant advancement in light-activated cancer therapy.
  • UCNP-based materials offer superior performance and innovative applications for improved cancer treatment.
  • Further research is crucial to bridge the gap between current studies and clinical implementation.